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Abstract

Introduction

This paper summarizes our studies of
IUD-related disease with those previously
published by others.
Our data are based upon 51
IUDs and 42 index cases of IUD-related disease
demonstrating specific processes.
Gross,
dissecting microscope, scanning electron
microscope and X-ray microanalysis examinations
were made of selected IUDs and associated
tissues.
Tissue associated with the IUDs
revealed inflammation in 59.4%, calcific
material in 6.3% and no abnormality in :l4.4%.
JUD-associated tissue responses were accompanied
by changes of the IUD; these changes involved
deposition of substances upon the IUD surface
and degradation of the JUDitself.
Disintegration of the IUD, its string or both, has been
repeatedly observed. The material deposited
upon the surface of the IUD included proteins
and calcium salts.
The changes which involve
the IUD and the host appear to be operative in
the genesis of IUD-related disease.
Inflammatory changes and infections are the most
commonIUD-related disease processes and are
also the mechanisms commonlyassociated with the
most serious complications of JUDuse, reproductive failure and death. We propose that serious
IUD-related disease is caused by or is a direct
consequence of processes which alter the JUDand
which potentiate inflammation and infection.
A
model amenable to testing is proposed.

In the US* many people prefer non-permanent
methods of contraception.
The IUD, despite
related health problems, remains a popular,
reversible means of birth control in this
country.
In the decade from 1973 to 1982 use of
0CPs decreased by 45.2% while use of the JUD
decreased by only 26.0%. The IUD is also the
mainstay of state supported contraception
programs in a number of so-called emerging
nations (29).
IUD usage may be traced back to ancient
ti mes and is para 11 e 1ed by the appearanee of
IIJD-related diseases (Table 1) (74). The social
and economic ramifications of such diseases are
greater than one might imagine. In 1985, AH
Robbins Co., producer of the Dalkon shield IUD,
filed for protection under Chapter 11, citing
immense legal costs and settlements as the precipitating cause of financial failure.
By
1986, G.D. Searle and Co., the makers of the
Cu-7 and Tatum-T IUDs, and 0rtho, manufacturer
of the Lippes Loop, had announced the withdrawal
of their devices from the market for similar
reasons.
It is impossible to objectively measure the
human suffering associated with JUD-related
disease but reasonable estimates of the financial cost may be computed. Table 2 indicates
the means by which Gupta (20) computed the
minimumtotal direct cost of IUD-related PID at
almost 75 million dollars per year. Whenall
varieties of JUD-related disease are included, as
wel 1 as indirect costs such as time lost and
decrements in productivity, the total economic
cost of IUD-related disease in the US may be much
higher.
This review summarizes and compares our
studies of IUD-related disease with those previously published.
The body of literature
appears sufficiently
comprehensive to permit
conclusions, derivation of hypotheses regarding
the origin of IUD-related disease and the
generation of recommendations for the future.
The uniquely human nature of IUD usage, the
absence of an animal model with which to explore
hypotheses and ethical constraints on human
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TABLE1
HISTORYOF IUD USAGEANDCOMPLICATIONS
HISTORY
OF IUDCOMPLICATIONS

HISTORYOF INTRAUTERINE
CONTRACEPTION
Sett~~g__ __
Oral hi story
400 BC
1100 AD
late 1800s
1909, 1923
1930
1930s
1936
1950s

1960s-70s

E_v_e_nt
____________

_

Smooth pebbles in camels' uteri
(Asia Minor).
Hippocratic writings describe
ebony, glass, gold, ivory,
pewter, wood and wool IUDs.
Avicenna writings discuss use of
IUDs.
Diamond-studded, platinum IUDs.
Richter, Pust - silkworm gut IUDs.
Grafenberg - silkworm gut and
silver wire IUDs.
Ota (Japan) ring.
IUDs banned in Japan by governmental
edict.
Plastic IUDs with "memory":
Margulies spiral, Lippes loop,
Birnbeg bow, Saf-T-Coil.
Metal devices: Majzlin spring,
M device.
Nylon coils (LfM device).
Copper-?, Copper-T, Dalkon shield.

1970s

ProgestasertTM
Antigon-F, Ypsilon, fluid-filled
devices.

Setting

Event

400 BC

Hippocratic writings record sepsis,
death associated with IUD use.

1900-1930s
1928, 1930

Pelvic sepsis and death.
Barth, Tietze: fatal pelvic
actinomycosis.

1960s

Margulies spiral:
rigid tail led to
male dyspareunia.
Birnbeg bow: bowel obstruction after
uterine perforation.
Majzlin Spring: myometrial embedment.
LEM: in situ fracture and embedment.
Dalkon shield: mid-trimester septic
abortion.
Medicated devices: moderate intermenstrual spotting.

1970s

U.S. Department of Health, Education and Welfare, 1978 (74)
TABLE2
OBJECTIV_E_ECONOMIC
CONSEQUENCES
_OFIUD-RELATED
DISEASE
850,000

Annual estimated cases of acute PIO in the US
Annual rate of PIO in women14-34 years old
Estimated percent of womenusing IUDs
Annual rate of PIO in womenusing IUDs
Annual rate of PIO in womennot using IUDs
Per cent PIO cases attributable
to IUD usage
Annual estimated cases of PIO due to IUD usage
(0.22X850,0DO)
Estimated hospital admissions of PIO patients
Estimated per case hospitalization
cost
Cost of IUD-related PIO hospitalization
( 187,OOOXO.
25X$l,000)
Estimated PIO cases with outpatient care
Estimated per-case outpatient cost
Cost of IUD-related PIO outpatient care
(187,000X0.75X$200)

$28,050,000

TOTALMINIMUM
DIRECTCOSTOF IUD RELATED
PIO

$74,800,000

1. 26%
8. 7 %
4.4 %
1.0 %
22.0 %

187,000
25~0 %
$1,000
$46,750,000
$200

Gupta, 1981 ( 20)
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experimentation necessitate a retrospective analysis.
We shall accomplish this by exploring:
1. the clinical
nature of IUD-related disease;
2. the relationship between clinical and pathological finrlings; 3. the role of morphological
and microanalytical techniques in clarifying the
genesis of IUD-related disease.
Materials

post-fixation was not done to avoid osmium peaks
during XRMA. Specimen pieces were rinsed in
buffer, washed thoroughly in distilled water,
dehydrated with graded ethanols and critical
point dried from liquid carbon dioxide using a
Bomar SPC-1500 critical
point drier.
Specimens
destined for XRMA
were mounted with carbon paint
on 25 mmcarbon stubs. Specimens for detailed
morphologic analysis were postfixed with an
osmium/semithiocarbohydrazide technique (45,60)
and critical
point dried as above. 0 Specimens
for XRMA
were coated with 100-150 A carbon using
an Edwards 306 sputter coater.
Specimens for
detailed 0 morphologic analysis were coated with
200-300 A gold-palladium under an argon
atmosphere in an Edwards 306 sputter coater.
Coated samples were examined in a JEOL SEM35
scanning electron microscope equipped with a
beryl 1i um window probe for XRMA. The system was
standardized using a copper grid mounted on an
aluminum stub. Specimens were examined for noncellular material as well as cells and deposits
on or changes of the IUD surface.
The presence
of non-cellular material, cells or microorganisms was recorded photographically.
Following
SEMexamination, XRMA
was done at a working
distance of 39 mm. Spectra were acquired from
various points on each IUD including sites with
crusted deposits and apparently uninvolved areas
of the tail, body and head of the IUD; peaks
within the spectra were labelled after acquisition.
The spectra obtained from the specimens
were compared with those derived from identical
IUDs 1~hich had never been worn and which
remained in the manufacturers' packages until
processing.

and Methods

The data presented herein include information derived from cases not previously
reported as wel1 as a series of IUD-related
actinomycosis cases previously published (62).
Our cases are derived from 415 IUDs collected
from Hermann Hospital /The University Hospital,
the ambulatory care clinics of The University of
Texas Medical School at Houston, Texas, public
family planning clinics of the city of Houston
and those contributed by private practitioners
of medicine. This collection was initiated
in
1977 and continues to date. Each of the IUDs
collected has been examined grossly by one of us
(WAS)and in approximately 50% of the cases
materi a 1s and tissues adherent to the I \JO have
been submitted for routine, light microscopic
histopathological
analysis.
The data presented
here are based in part upon 51 IUDs collected
during 1985. Tissue specimens from 31 of these
cases (60.8%) were examined in detail by LMfor
this study. The study al so includes data
derived from 42 inrlex cases carefully selected
from the collection.
The index cases consist of
the following:
9 cases of IUD-associated actinomycosis, l case with characteristic
cytopathological findings of IUD-related PID, 1 case of
'encrusted'
IUD characteristic
of long-term IUD
use, one case characteristic
of intraendometrial calcific material associated with
IUD use, 28 cases not associated with disease
where the IUDs were worn for twenty months or
more, and IUDs from two womenwith characteristic
IUD changes and PIO.
The nine cases of IUD-associated actinomycosis, specimens from which were studied by
LM, SEMand histochemical methods, have been
reported previously (62). Routine histological
examinations of paraffin-embedded tissues from
the 1985 cases included H&E, PAS with and
without diastase digestion, Brown-Rrenn,
Ziehl-Neilsen,
and GMSstains.
Special preparations of tissues,
IUDs or IUD-strings from the
index cases included von Kassa, ARSand
Bunting's MoBstained sections, a Papanicolaou
stained CV smear, and IUDsurface crusts stained
with ARS.
Careful gross, dissecting microscope and
SEMexaminations were made of selected IUDs.
Paraffin-embedded sections of IUDtails and
IUD-associated 'crusts' stained with H&E, ARS,
GMSand MoBwere examined by routine light and
polarization
microscopy. Portions of the IUDs
and their tails as well as the ARS stained IUD
were examined by SEMand XRMA.
IUDs 1~ere prepared for SEMby gently
cutting each specimen into pieces approximately
1 cm in length.
Each piece was fixed in
phosphate buffered, 2% glutaraldehyde; osmium

Results
The IUDs received during 1985 included the
following types: Lippes loop, Oalkon shield,
Saf-T-Coil, Cu-7, Cu-T and Margulies spiral.
The numbers of each IUD type and their frequency
are shown in Table 3; this table also contrasts
the 1985 cases and the index cases with the
numbers and frequencies of IUDtypes collected
during the period 1977-1986.
Of the 51 IUDs collected, 9 were received
without adequate historical
documentation while
42 were accompanied by sufficient clinical
history to allow correlation between clinical
and pathological findings.
The original gross
descriptions of the IUDs were insufficient
in 24
cases; upon later examination by one of us
(WAS), 10 of these 24 cases (41.7%) were found
to have deposits on the IUD (Fig. 1) or string
surfaces or there were structural changes of the
IUDor string.
A total of 28 cases had grossly
recognizable structural changes; each of these
IUDs had been in place for no less than 2 years.
The gross structural changes seen included
deposits of calcareous material (Fig. 2), total
breaks of the IUD, chips and cracks of IUD surface, absence of, breaks of or deposits upon the
IUD string, and combinations of the above.
Thirty-two IUDs (62.7%) came with sufficient amounts of attached tissues to permit
histopathological
examination.
In 24 of these
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TABLE4

TABLE3

IUD-RELATED
ACTINOMYCOSIS

T_r~~_AND
FREQUENCY
OF IUDs COLLECTED
ANDSTUDIED
Cases presented,

_NlH __

Type
Lippes loop
Cu-7
Cu-T
Margulies spiral
Saf-T-Coil
Dalkon shield
Lippes loop+ Cu-7
Index cases,

Definition of the syndrome:
Actinomycotic pelvic infection associated with
IUD use; ranges from organisms in CV smears
(4.0-25.5%) to pelvic abscesses (0.4-1.4%).

N=51; 1985
21
20
6
2
1
1

C41.2%)
(39.2%)
(11. 8%)
(3.9%)
(2.0%)
(2.0%)

Characteristics
1.
2.

Age range:
Symptoms:

3.

Signs:

4.

Duration:
IUDtypes:

80.4%
N=42; 1977-1986

.I,y_pe-:_......
__ _
Llppes loop
Cu-7
Saf-T-Coi l
Dalkon shield
unknown*

N

Duration:

%

5.

27 64.3%
9 (21.4%)
2 (4.8%)
3 (7.1%)

6.

Extent of
disease:
Surgical
therapy:

1 (2.4%)

Lippes loop+ Cu-7 = 85.7%

Schmidt et al.,

of the syndrome:
23-54 years.
pain, fever, sweats, menstrual
irregularities.
pelvic mass, fever (38-40.5 C),
non-specific.
3 days - 14 months.
variable - reflects patterns
of use.
6 months - 25 years; 84.7% l_
3 years.
62.5% uni- or bilateral
ovarian abcess.

tubo-

65.6% with subsequent total
loss of reproductive
capacity.
1980 [63)

Total coll ecti_o_n_,_
-~=3_2_6_;
__1_9_7_7_-_1_9_~~
Type
Li ppes 1oop
Cu-7
Cu-T
Margulies spiral
Saf-T-Coi l
Dalkon shield
Progestasert
unknown*

N

was concomitant chronic inflammation in a
Fallopian tube segment.
The 9 cases of IUD-associated actinomycotic
disease have been reported elsewhere (62) (Table
4). These nine cases demonstrate that female
reproductive system actinomycotic disease is
related to IIID use. The occurrence of this
infectious disease, which is otherwise rarely
encountered in the female reproductive tract, is
directly related to the duration the IUD has
been worn. In our nine cases, and in similar
cases reported in the literature
up to that
time, 80% of the womenafflicted with
IUD-related actino1nycosis had worn their IUDs
for more than three years. This infection is
serious, commonly results in permanent infertility and is not related to life-style,
sexual
habits, race, socioeconomic status or the type
of IIJDused.
In three of our nine Actinomyces cases 1~e
observed characteristic
Gupta bodies (20-22,24)
in CVsmears. Gupta bodies, actually complex
colonies of microorganisms including Actinomyces
and other pathogens, may be seen in IUD-related
PIO caused by organisms other than Actinomyces
( 20). One index case demonstrates the
appearance of such organisms on CVsmears. The
patient, a womanwho had worn her Saf-T-Coil for
13 years without replacement, was treated for
severe PIO within one month of finding the cytopathologic changes on her CVsmear (Fig. 3).
Birefringent,
crystalline,
ARSpositive
staining material is often encountered in
endo,netrial tissues from women1~ith long term
(>2 years) IUDuse (33). Both H&Eand ARS

t%) -

98 30.1%)
155 (47.5%)
6 (1.8%)
3 (0.9%)
25 (7. 7%)
25 (7.7%)
6 (1.8%)
8

(2. 9;:)

Lippes loop+ Cu-7 = 77.6%
*Not identified because of destruction or doesnot fall within recognizable category.
32 cases (75%), adherent tissues were obtained
from the surface of the IUD itself.
In 8 of
these cases (25%) tissues were obtained from a
coincident diagnostic or therapeutic procedure
(eg., total abdominal hysterectomy, dilatation
and curettage or endometrial biopsy, or tubal
ligation).
In 19 cases (37.3%) there was no
evidence of material attached to the IUD which
could be used for histopathological
examination.
Histopathological examination of adherent
or associated tissues revealed chronic inflammation in 28.1% of cases, acute inflammation
in 31.3% of cases, calcific material in 2
instances (6.3%), and no evidence of histologic
abnormality in 11 instances (34.4%). In both
specimens where calcific material was found in
adherent endometrial tissues, the IUDs had been
in pl ace for at least 20 months. In none of the
cases were organisms found in histologic preparations.
In one case with tubal ligation there
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Fig. 1:

Fig. 3:

Fig. 2:

A Lippes loop IUDafter removal; arrows
indicate adherent tissue which may be
removed for histologic examination.
Bar = 2cm
A Dalkon shield IUD; there is adherent
tissue and an extensive biodeposit.
The small white flecks, seen as
confluent white areas on the distal
ends of the arms (arrows), are characteristic
of surface depositions of
calcium salts.
Bar = 3cm

Fig. 4:

stains identify calcium salts in these
birefringent
materials.
One of the index cases
provides a characteristic
appearance of these
crystalline
substances in H&Estained sections
of endornetrial tissue (Fig. 4). These calcific
materials seem to fonn on the surface of the
IUD. Figure 5 demonstrates an ARSstained IUD
which had been in place for more than 2 years.
This IUD and its string were also examined by
SEMand subjected to XRMA. The deposits of
material on the IUD string surface are shown
clearly in Figure 6. These deposits
demonstrated spectra of Ca, P, S, and Cl when
subjected to microanalysis; Figure 7
demonstrates a typical Ca distribution
map for
the string deposits.

•

~

1-----1

.___,

••

••...

~

;.

a

-•

- f!.,.

4

2

•

•

,.JI,'

•

Light micrograph of a CVsmear stained
with Papanicolaou technique.
The
centrally located fuzzy structure
(arrow) is a cluster of bacterial organisms - a Gupta body. Superficial
(arrow-s) and intermediate (arrow-i)
epithelial
cell nuclei are seen; many
PMNsare present. Bar= 40µm
Light micrograph of a multilammellar,
calcific body seen in a paraffin section
of endometrial tissue associated with
an IUD. The patient was asymptomatic
and her IUD had Ca concretions on its
surface.
H&E. Bar= 4Qµm

Surface deposits are observed commonlyon
IUDs which have been in place for at least two
years and virtually uniformly on those in situ
for three or more years.
The crusts are not,
however, pathognomonic of IUD-related disease.
Twenty-eight of our index cases were received
from an OB/GYNpractice composed of high-middle
to upper socioeconomic class womenof uniformly
conservative, monogamouslife style (as defined
by the contributing physician).
None of these
women, all of whomhad their IUDs in place at
least 20 months (range: 20 months-13 years),
were symptomatic. In this group of 28 IUDs,
there were ten which had obvious surface deposits of calcific nature which were grossly identical with those previously published (33).
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Fig. 5:

5
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~
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Fig. 6:

Fig. 7:

A Lippes 1oop IUDremoved from a patient
after 4 years of continuous use. The
IUD is ordinarily clear white. Calcium
deposits (arrow) have been stained with
ARS. The IUD is fragmented because
pieces have been taken for SEMand
XRMA. Bar= 2cm
Scanning electron micrograph of a portion of the string from an IUD. This
specimen was coated with carbon only.
There is an obvious coating of the surface of the string; this coating has a
fibrillar
appearance and is fragmented.
Bar = lOµm
Map of Ca localization on the string
shown in Fig. 6. Note the correspondence of the Ca localization with
the deposits on the surface of the IUD
shown in Fig. 6. Bar = lOµm

In several index cases we carefully examined
the deposits on both the IUDs and the strings.
Amongst these cases, two womenhad multiple
sexua 1 partners, had worn their Li ppes 1oop IUDs
for ten years, had prominent deposits on their
IUDs and had unusual female reproductive tract
infections.
One patient had actinomycosis and
aspergillosis
and the other had actinomycosis and
botryomycosis.
The organisms were demonstrated
in CVsmears (Gupta bodies), on histologic sections of endometrial tissues, on IUD surfaces and
within the crusts on IUD body and tail (Fig. 8).
The crusts on these IUDs and their tails
were studied in detail.
The crusts were present
on the surfaces of the IUDs and on the strings at
about the level of the exocervical as where the
string exits from the endocervical canal (Fig.
9). Portions of the strings with attached crusts
were sectioned histologically
after paraffin
embedment. Parts of the crusted IUDs and their
strings were examined by SEMand XRMA.
The paraffin sections of the crusted strings
demonstrated a complex deposition within which
microorganisms were easily found. The depositions consisted of dense, amorphous, PAS positive
material adjacent to the string or IUD body, a
layer of calcific material staining red with ARS,
black with van Kassa and blue with the MoB
stains, an outer layer of mucoid material and a
thin surface coat of cells, cell debris and
birefringent
ARSpositive crystals (Figs. 10 &
11). In both instances the deposits stained blue
with the MoBand black with the van Kassa techniques, indicating phosphate rather than carbonate salts of calcium; Ca, P and S peaks were
also seen on XRMA.
We commonly find Ca salts in materials
adherent to IUDs which have been in place longer
than 2 years, whether or not there is IUD-related
disease.
Conversely, we have not encountered
prominent IUD surface depositions with or on
IUDs in place less than 12 months. When
microorganisms are found they are always associated with the IUD or string surface deposits
(Figs. 12-15). Typically, a mixture of organisms is seen. The mixture usually includes
Brown-Brenn positive and negative species; GMS
positive types of microorganisms, including
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Fig. 8:

Fig. 9:

10

Fig. 10:

Fig. 11:
t------'

Fig. 12:

_______

.._ ____
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LMof crust removed from an IUD of a
patient with actinomycotic infection.
The Actinomyces organisms are stained
with silver and appear as long, slender
black fi 1aments (arrow). Gomori
methenamine silver.
Bar= 40µm
An IUD string with surface deposits,
embedded in paraffin.
Multiple sections
have been taken from the block. The
block face reveals the cut surface of
the surface deposits and the string
itself.
The proteins appear brown
(arrow head), the string (S) is partially opaque and the Ca deposits
have a white granular appearance
(arrow). Bar = 1mm
Light micrograph of a section taken from
the block shown in Fig. 9. The string,
made of plastic, washed off the
slide during staining and left a
central clear space around which the
surface deposit is found. Proteins in
the surface deposit stain red (arrow).
H&E. Bar = 40\Jm
LMof a section parallel to that seen
in Fig. 10. The section has been
stained identically but is viewed with
polarized light.
The bright band of
material at the arrow is a remnant of
the sectioned IUD string.
The periphery
of the material deposited on the string
is birefringent.
The birefringent
material stains with ARSand is
apparently a Ca salt.
H&E. Bar = 4Q.Jm
SEMof the elbow region of a Cu-7 IUD.
The median ridge (single arrow) is from
the mold in which the IUD was made.
There are a variety of deposits upon
the surface of the IUD. The double
arrows indicate non-cellular deposits
characteristic
of proteo-calcareous
material.
Large numbers of cells are
scattered over the surface of the IUD
(triple arrow). Bar= lOµm

W.A. Schmidt, K.L. Schmidt
Fig. 13: Higher magnification of the IUD seen in
Fig. 12. Detailed view of the cells
suggests the presence of RBCsand WBCs.
Note bacterium at arrow. Bar= 15µm
Fig. 14: Portion of a Dalkon shield IUD. There
is an obvious coating on the surface of
the IUD; this coating is elevated in the
region of the arrow. The entire surface
of the IUD is coated. Bar = 20\lm
Fig. 15: Detail view of the coating of the IUD
seen in Fig. 12. This IUD came from a
womanwith actinomycotic infection of
the female reproductive system; she had
worn the IUD for more than three years.
The coating is formed of many bacterial
organisms. Bar = 2).Jm
bacteria and fungi, are usually intimately
associated with the crusts (Figs. 8 & 15). We
have not encountered acid fast stained bacteria
but believe this relates to technical difficulties when using this stain with paraffin
embedded material.
The crusts from the two index
case IUDs with severe PIO provided definite
Ca and P peaks on XRMA
(Figs. 16 & 17).

Fig. 16:

Microanalysis of an IUD from one of the
two index cases with severe PIO
following long-term (greater than 3
years) constant IUD use. There are Ca,
S, P, and Cl peaks contributed by the
surface deposits; the Cu and Zn peaks
represent components of the IUD itself,
Fig. 17: Microanalysis of the string from
another patient with PIO. Strong Ca
and P peaks are present.
There were
obvious deposits upon the surface of
the string in the region where this
spectrum was obtained.
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Discussion

4. IIJD-rel ated disease tends to affect
certain kinds of patients.
These womenoften
have multiple sexual partners and usually have
worn their IUD for three or more years.
5. Minor IUD-related disease is usually
not related to alterations
of the IUD itself or
to histopathologic changes in the endometrium.
6. Major IUD-related disease is related to
IUD usage, to the time the IUD has been in situ
without replacement, to the severity of alterations of the IUD surface and is virtually always
inflammatory or infectious in nature.
We have encountered fewer cases of serious
IUD-related infectious and inflammatory disease
amongst the 51 cases collected in 1985 compared
to the 42 index cases which were collected
earlier because our clinical colleagues now
regularly remove or change IUDs after two years
of use.
Physiologic Effects of IUDs
Numerous studies have explored the biologic
effects of IUDs (Table 5). Multiple physiologic
parameters have been analyzed without identifying
either the mechanism of action of IUDs or the
origin of IUD-related disease.
The most important conclusion from the physiologically
oriented studies may be found in the second FDA
report on IUDs (74):
"It is not yet completely understood how
any particular IUD prevents pregnancy. It is
currently believed that the numerous cellular
and biochemical alterations
induced in the endometrium by the presence of the device are
responsible.
The various devices may actually
have several different mechanisms of action,
one perhaps being more important with a
particular device than others.
However, in al 1
species studied, there is one commonthread of
similarity,
i.e., the development of a local
endometri a 1 reaction as evi deneed by a spec i fie type of leukocytic infiltration.
This
reaction seems to interfere in some manner with
the implantation of the fertilized
ovum in the
uterine cavity and is currently believed
to represent the primary mode of action of the
IUD".
The physiologic studies of IUDbearers have
documented that a host response occurs to the
IUDand that this response may be IUD-specific.
Characteristics
of the host response have been
clarified by morphologic and microanalytic studies. These studies reveal greater detail about
the nature of the host/IUD interaction and the
changes which occur to the host and IUD. They
also shed considerable light upon the mechanisms
involved in IUD-related disease.
Such studies
have involved cytologic, histologic, TEM, SEM
and microanalytic methods.
Host Response to IUDs
Initial cytologic studies performed during
the 1970s detected IUD-induced host responses
which affected both the host tissues and the
IUD. Sagiroglu and Sagiroglu showed that smears
of IUDs removed after being in place from five
hours to 39 months had a surface accumulation of
host cells but that bacteria were associated
with the IUDonly transiently
for the first five
days ( 59). In 1971, Highman reported on the

It is important to exclude the possibility
of bias introduced by acquisition of only certain types of IUDs; both collection and population biases in our collection are minimized by
the wide spectrum of medical practices from
which these IUDs originated and the diversity of
IUDs obtained.
Our studies are based upon a
collection which contains the same proportion of
IUDtypes seen in commonusage patterns in the
US (29). The types of IUDs collected during
1985 are generally the same as the 1977-1986
collection,
although fewer older style IUDs are
represented in the later group. Al1 42 IUDs
representing the index cases remain in use
today.
From the 93 cases we have studied and those
described in the established literature
it is
possible to recognize commonpathologic mechanisms operative in a variety of IUD-related
diseases and to establish general conclusions.
It is apparent that early diagnosis of
IUD-related disease requires morphologic analysis of IUDs, associated tissues or CV smears.
Specimens submitted for analysis must be accompanied by appropriate clinical information.
Without these clinical data the pathologist is
bereft of appropriate perspective and must
necessarily limit the interpretation
of the findings present.
The IUD and any associated
material should be carefully examined and the
latter must be examined microscopically.
In
most of the cases (65%) we have presented in
this paper the tissues associated with the IUDs
were abnormal. In our experience, examination
of the IUD itself generally lends little
understanding to the condition of the IUD-bearer
while examination of the associated tissue does.
Conjoint examination of both the IUDand the
host tissues and correlation with clinical
details is the most productive.
From our
experience we conclude that:
1. IUDs are altered while in utero.
The
alterations
occur as a surface phenomenon which
affects the IUD, any attached materials, such
metal coils, and the string.
Calcification
is
the most commonalteration
found. The process
of Ca salt deposition appears to be time
dependent; IUDs in place for longer than two
years commonly have such deposits.
2. IUDsurface depositions are associated
with a variety of microbial organisms, especially in those instances where PIO is clinically apparent.
The microorganisms are usually
intimately related to the surface deposit.
Severe IUD-related inflammatory disease is virtually always associated with prominent IUD surface deposits, but prominent surface deposits
are not always associated with severe inflammation or disease.
3. Inflammatory changes in the endometrium
are commonwith IUD use. These changes are most
severe in those instances where the womanis
symptomatic. The severity of the endometrial
changes appears synchronous with and directly
proportional to the extent of IUD surface
alteration.
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TABLE5
BIOLOGICEFFECTOF IUDS
Physiologic Studies
Year

IUO/Agent

Effect

2.
3.
4.
5.
6.
7.
8.
9.

1974
1979
1980
1980
1980
1980
1981
1981
1981

Cu-T200
Cu-7
Cu-T200
Cu-SC
Cu-IUDs
Cu-T
Cu-T200
cu+2ion
ns*

10.
11.
12.
13.

1982
1983
1965
1970s

Cu-T
M.spiral
ns*
ns*

Serum progesterone 1-2 days late; earlier onset of menses (25).
Endometrial estradiol-17- B -dehydrogenase unaffected (69).
No changes in serum copper or urinary copper excretion (54).
Elevated copper in cervical mucus (55).
Decreased serum iron and transferrin
saturation; hemaglobin constant (15).
Ovarian function unaffected; ovarian-endometrial asynchrony (12).
No changes in coagulation factors (41).
Caused dose dependent increase in myometrial contractility
(43).
Lower uterine fluid fibrinolytic
activity.
Increased serum proteinase inhibitors in uterine fiuid.
Increased urokinase in uterine fluid (4,6,7,41).
Lower daily levels of hPRL (1).
Elevated endometrial tissue PGF but not PGE (74).
Severe infection or increased tubal transport rate.
Inflammatory response (74).
Increased lysosomal hydrolases, protein, non-protein nitrogen and urea.
Increased AlPase, AcPase, glycogenesis, phospholipids, oxygen consumption, total
proteins, RNA/DNA
ratio (74).
Asynchronous endometrial development.
Elevated serum C-reactive protein (74).

1.

ns:

IUDtype not specified

association of calcific bodies with IUD use
(27). In that same year, Gupta et al. discussed
the changes which occur on the surface of the
IUD and suggested that the host is capable of
degrading the IUD (23). The studies of Fornari
demonstrated that IUD use unequivocally results
in tissue changes, which affect both the endometrium and the endocervix, appear in diagnostic
CV smears ( 13). They showed these changes,
which may mimic neoplastic alterations,
were
inflammatory in origin.
By 1979 it was apparent that IUDs were
associated with a pronounced host response and
that deposits occurred on the surface of IUDs.
Trebichavsky and Nyklicek showed in a TEMstudy
directed at the cellular response of the host to
the IUDthat the entire IUD was covered by host
cells by 48 hours after insertion (68). Over
time the cellular covering changed from PMNs
to macrophages. Eventually the IUD became
covered by a variety of cellular types and
debris and 47%of IUDs worn for three or more
years had bacteria on their surface even though
35% of these were sterile by culture methods.
In 1981 two important papers defined the
nature of the host cellular response to supposedly biologically inert IUDs. Casslen et al.
compared the cellular composition of uterine
fluids from 75 otherwise healthy Cu-T200 IUD
users with similar fiuid obtained from 48 nonusers and found significant
differences (5).
The IUD-user uterine fluids demonstrated little
or no change in the number or nature of endometrial eel ls and showed a modest increase in
the numbers of mast cells and eosinophils.
Marked changes were seen in the numbers of

lymphocytes, phagocytes and granulocytes of the
uterine fluids of IUD users. There was a
thirty-fold
increase in the number of lymphocytes and phagocytes, the latter of which also
accounted for roughly one-third of the total
cells in the fluid.
PMNsaccounted for almost
two-thirds of the cells in the uterine fluid and
showed a 300 fold increase in number.
A similar study by Kobayashi et al. in
Japan confirmed the host cellular inflammatory
response to the IUD (39). They studied 26
healthy womenwho had used the Ota ring for one
to five years duration and quantified the cells
obtained from the IUDs at removal • They found
an IUD cellular 'coating' composed of 49%
macrophages, 42.7% PMNs,4% endometrial cells,
1.3% mast cells and 3%assorted other cells.
On
the average there were 65.5x10(4) cells/IUD; the
range was 1.3-280x10(4) cells/IUD.
They also
identified inhomogeneity in the host response to
the IUD and divided their patients into two
groups based on more or less than 5x10(5)
eel ls/IUD. In the former category there were 10
womenwith an average of 144.3+79.2x10(4)
cells/IUD while in the latter group 16 womenhad
an average of 18.3+3.3x10(4) cells/IUD.
This
variation in host response documented at the
cellular level previously has been seen histological ly. In the histopathologic studies,
however, the variability
of the host response
seems to be related to the type of IUD used and
its duration of use. The first histologic study
by Willson et al. in 1965 examined endometrial
changes in 292 womenwearing polyethylene
Margulies spiral IUDs (72). They found the
endometrium responded to the ovarian cycle

744

Review of IUD-related Disease
temporal relationship of inflammation and symptomatology in 393 womenwho used a Lippes loop
IUDfor 18 months or longer ( 51). Amongthe 60%
who remained asymptomatic for 3 or more years
there was a 2.5% incidence of endometritis.
The
20% of womenwho became symptomatic during
the first 3 years had a 20% incidence of endometritis and the 20%of womenwho became symptomatic after more than 3 years of continuous
IUDuse had a 40% incidence of endometritis.
In
all the womenthe symptomatology was menometrorrhagia and pelvic pain.
In some instances, the type of IUDdoes,
however, influence the host response. Mestranol
loaded spring coil silastic IUDs, for instance,
are associated initially
with endometrial
hyperplasia and later with endometrial atrophy
(11). Whether simultaneous drug delivery ameliorates the inflammatory response is not clear
in this study because the IUDs were worn no
longer than 12 weeks. Similar problems plague
interpretation
of tissue responses to progesterone loaded IUDs which are designed to be
used for no longer than 12-24 months. The addition of elemental copper to the IUD does
increase the inflammatory response (10,53) and
it has been shown that intrauterine metallic
copper results in PMNinfiltrates
in the endometria of animals (10).
It is now apparent that polyethylene,
polyethylene plus metal and metallic IUDs all
are associated with endometritis (49). In fact,
the inflammatory process involves the Fallopian
tubes as well. In 1984, Coll ins et al. (8)
demonstrated, in a population of 73 women (20
IUD users, 25 OCPusers and 28 barrier method
users) an excess of Fallopian tubal inflammatory
changes in those who used IUDs. Others (49)
have also shown that IUD use is associated with
both endometritis and salpingitis.
A characteristic
example of IUD-type specific endometrial inflammatory response is provided by the Majzlin spring IUD. Ober et al.
studied 69 endometrial biopsies from womenwith
this stainless steel IUD (50). These biopsies
came from 68 patients, 12 of whomwere asymptomatic.
The asymptomatic patients had worn
their IUDs for 2 to 10 months and significant
inflammatory changes were seen in 16.6% of their
endometrial biopsies.
Amongst the 56 symptomatic women, who had worn their IUD for 0.5 to
15 months, 78.6% of the biopsies had significant
inflammatory changes. In 36.3% of all the biopsies there were bacteria demonstrated by
Brown-Brenn staining of paraffin sections.
In
the case of the Majzlin spring IUD, which was
composed of iron, chromium, nickle, and to a
lesser degree manganese, silicon, sulfur, carbon
and phosphorus, the endometritis seems to have
been metal lo-chemical in origin.
Chromiumand
nickle are particularly
suspect as primary irritants; the bacteria were not thought to be the
primary cause of the inflammatory process.
Electron microscopic studies have revealed
exciting details about the relationship between
the host and the IUD. The IUD itself,
regardless of type, produces fundamental changes
in the cellular architecture of the reproductive

(although there seemed to be some delay in the
endometrial response), congestion of the superficial vascular sinuses of the endometrium and
increased edema forrr,.:tion. They al so
demonstrated a 19% incidence of chronic endometritis in those womenwho had worn their IUD
for 4 - 25 months.
The role of inflammation in IUD-associated
histologic changes of the endometrium has been
confirmed upon multiple occasions.
In 1968,
Ober et al. reported on 200 endometrial biopsies
from womenwho had worn various kinds of IUDs
(52). This group of patients included 107 symptomatic and 93 asymptomatic women. In the endometrial biopsies from these womenthey
identified the following as minor lesions:
lymphocytosis, granulation tissue, focal gland
loss and asynchrony. Amongmajor lesions they
included acute and chronic endometritis.
The
biopsies from the 107 symptomatic womenrevealed
25.2% of womenwith major lesions and 45.8% of
womenwith minor lesions.
Amongst the asymptomatic womenonly 9.7% had major lesions seen
in their endometrial biopsies while 50. 5% had
minor lesions.
With some notable exceptions to be
discussed below, the endometrial inflammatory
response associated with IUD use does not
necessarily seem to be IUD specific.
Moyer and
Mishel l studied the endometrial response to
Lippes loop IUDs which had been placed preoperatively in 167 women scheduled for hysterectomy
( 46). The specimens were exa1nined at various
times after insertion, the range being a few
hours to as long as five years. All specimens
demonstrated inflammatory responses composed of
PMNs, plasma cells, and mononuclears; the mononuclear infiltrates
persisted for years.
An
elevation of endometrial cavity fluid protein
content was also characteristic
of womenwearing
I I/Os.

The nature and intensity of the pervasive
endometrial inflammatory response, particularly
in the case of polyethylene IUDs, seem to be
related to the time the IUO had been in situ.
Moyer et al. studied 75 patients who had Lippes
loop IUDs placed prior to hysterectomy (47).
They found a transient,
post-insertion
contamination of the endometrial cavity with low
virulence bacteria, a contamination which was
spontaneously resolved in all cases within 48
hours after insertion.
Those endometria which
contained the IUDs for up to six days before
hysterectomy demonstrated a stromal inflammatory
infiltrate
composed of PMNs, lymphocytes and
monocytes. When the IUDs had been in place for
7-49 days the inflammatory infiltrate
was composed of neutrophils,
plasma cells and
increasing numbers of monocytes and there were
also focal ulcerations of the endometrial surface. The inflammatory infiltrates
persisted in
those womenwho wore their IUOs for several
months before hysterectomy.
Similarly, Hayashi
et al. found in 145 womenwho had used a variety
of IUDs, that the extent of endometrial inflammation was greater in those who had worn their
IUDs for more than two years (26).
Ober et al. studied in greater detail the
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tract epithelium irrespective
of the inflammatory process.
In 1984, Wollen et al. found a
change in Fallopian tube epithelial
cell populations of 12 healthy, non-pregnant womenusing a
variety of IUDs (73). They demonstrated a
decrease of ciliated endosalpingeal cells from
40'.~to 20%.
Other studies have examined in greater
detail the ultrastructural
changes associated
with IUDuse. In 1976, Hsu et al. studied endometrial tissues obtained from 7 patients who
ranged from 39-51 years of age and who had Cu-T
or Cu-7 IUDs placed from 2 to 54 days prior to
hysterectomy ( 28). By LMthey found an i nfl ammatory response which was present in the lumen,
glands and stroma and which was greatest at the
11!0 sites.
By TEM, there were superficial endometrial erosions at the IUD contact site, intraepithelial
lymphocytes and neutrophils, giant
lysosomes evidencing cellular damage short of
cell death, loss of cilia and an absence of the
nucleolar channel system where such a channel
system should be found. On SEMexamination they
found endometrial surface epithelial
cell microvillar changes, a prominent mucoid inflammatory
response, erosions of the surface epithelium and
RBCs and WBCsscattered over the endometrial
surface.
Using energy dispersive microanalysis
they were unable to detect copper in the specimens, their limit of resolution being
5x10(-18)g/200µm diameter. The absence of
detectable Cu in the tissues is curious since
the element is clearly a stimulant of the endometrial inflammatory process (10,53).
Absence
of Cu also was shown by Gonzalez-Angulo and
Aznar-Ramos who studied endometrial tissues from
12 womenwho wore Cu-T200 IUDs for 6-12 months
(18). In their study they were unable to
demonstrate tissue Cu using the rubeanic acid
histochemical technique and energy dispersive
XRMA. They also demonstrated evidence of cellular injury on TEMby noting mitochondrial matrix
vacuolization, myelin figures and increased numbers of lysosomes.
Sheppard and Bonnar concentrated upon
microvascular changes in IUD exposed endometria
as demonst rated by TEMstudies ( 63). They
studied endometria from 15 patients who had worn
a variety of IUDs for various periods of time
ranging from 4 to 48 months. The majority of
tissue changes were associated with the actual
sites of IUD contact although similar but lesser
changes were seen in adjacent endometrium. The
alterations
were associated directly with the Cu
content of the IUD, the proximity of the IUDto
the endometrium and the area of the IUD/endometrial interface.
The pathologic features
observed included microthrombi, platelet/fibrin
aggregates in endothelial gaps of the superficial stromal capillaries
under the IUDs, an
associated stromal hemorrhage and superficial
erosi ans of the endometri al surface.
IUD/String Alterations
IUD-associated histologic responses are
accompanied by changes which involve the IUD
itself.
These IUDalterations
may be
categorized under the concept of IUD
biotransformation.
IUDbiotransformation
is a

biphasic process comprised of: 1. biodegradation of the IUD and/or the string, and 2.
biodeposition on the IUD and/or the string (61).
Table 6 summarizes major contributions to the
concept of IUD biotransformation.
The first observations of IUDbiotransformation were published by Gupta et al. (23) who
demonstrated encrustation and disintegration
of
Lippes loop IUDs using incident LM. Johnson et
al. studied IUDencrustation in greater detail
using incident LMand x-ray diffraction
quantitative
analysis (30). They demonstrated
calcium salt deposition on various kinds of
IUDs, considered calcium carbonate to be the
major component of such calcification
and
suggested that Ca deposition tended to increase
with the duration the IUD was used. Biale et
al. (3), using SEM, chemical and stress analysis
of Lippes loop IUDs, found calcium carbonate
upon and corrosion of the surface and increased
rigidity the longer the IUD was in place.
Rosenfeld et al. (58), using SEMand XRMA,
demonstrated similar Ca salt deposition on the
Cu wire of Cu-7 IUDs. Keith et al. (34), also
using SF.Mand XRMA,performed a detailed study
of IUDcrystalline
surface deposits on various
I IJ[)s. They revealed apatite as the major
crystal of the calcification
and specifically
identified an euhedral crystal rosette composed
of [Ca5(P03l3(F,Cl ,OH)].
Disintegration of the IUD, its string or
both has been repeatedly observed; this is the
process which we prefer to name biodegradation.
Changes in metallic components of IUDs, particularly Cu wires, are not altogether
surprising since the metal is placed in an
electrolyte
solution for prolonged periods of
time. Larsson et al. studied wire weights of
coiled Cu wire IUDs and demonstrated a decrease
in wire weight over time (42). The change was
minimal and did not appear to affect contraceptive efficacy.
Kosonen and Thiery, using LM,
similarly demonstrated wire corrosion and fracture of IUDs with coiled Cu wire (40). Similar
results have been obtained in animal studies
using wires made from a variety of metals.
Using XRMA
and metallographic techniques Gonen
et al. (17) demonstrated fragmentation of and
deposition on the surface of wires composed of
pure Au, Pt, Cu and alloys of these three
metals. The deposits on the outer surface of
these wires revealed elemental Ca, Cl, and S by
XRMA.
Destruction of the plastic JU[) or its
string seems at first glance unlikely.
In fact,
IUDs were reintroduced early in the 1960s
because plastics were available and because they
appeared to be biologically inert; it was
suggested that the body essentially ignored the
IUDs made of polyethylene.
The host reaction to
the IUD involves not only a cellular response
but includes the capacity to degrade synthetic
materials previously thought impervious to
biologic action.
Biologic degradation of both
nylon materials and Vicryl and Dexon sutures,
the latter two being composed of copolymeric
glycolide and lactide and copolymeric glycolic
acid respectively,
has been demonstrated
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TABLE6
IUD BIOTRANSFORMATION
Reference

Year Study Type

Conclusions*

(24)

1971 Incident LM

Encrustation

(66)

1975 Incident LM, TEM,
bacteriologic

Disintegration of and bacterial
(Dalkon shield).

( 67)

1975 Incident LM, TEM, Wicking effect
bacteriologic

{30)

1976 Incident LM,
X-ray diffraction,
quant. analysis

Ca salt deposit on IUD surface (various types); Calcium
carbonate, the major crystalline
component, tends to increase
w/ duration~
situ.

(14)

1976 SEM

Surface alterations

( 3)

1978 SEM,
Calcium carbonate deposition,
chemical analysis,
rigidity {Lippes loop).
stress analysis

{63)

1980 SEM, TEM,
XRMA

Bio-material: cells, fibrin.
Inorganic material:
calcium deposits.
Tendency to increasing calcium deposits with time (Lippes loop,
Saf-T-Coil, Dalkon shield, Cu-7, Progestasert™).

( 17)

1981 XRMA
metallography

Au, Pt, Cu and duplex wires; rats.
Ca, Cu, Cl , S formed deposits with inner and outer layers;
fragmentation.

{58)

1981 SEM, XRMA

Ca deposits

{42)

1981 Wire weights

Minimal decrease in wire weight over time; not related
contraceptive effectiveness {Cu devices).

( 40)

1983 LM

Corrosion and breaking of wires {Cu devices).

( 2)

1983 SEM

Bacteria on and in Dalkon shield tail;
and acts as wick.

( 57)

1984 SEM

Deterioration

{35)

1985 SEM, XRMA

Detailed study of crystalline
surface deposits; various IUDs;
apatite, euhedral crystal rosette seen [Ca5{P04)3 {F,Cl ,OH)]
on 15 year in situ Lippes loop.

{36)

1985 SEM, XRMA,
X-ray diffraction

Cellular and acellular crust on various IUDs; Ca salts
present {phosphates?); crust/fibrillar-amorphous
layer/IUD
interface seen suggests sequential crust formation.

*see text references

for detailed

(Lippes loop).

of structurally

colonization
unique tail

and depositions

within string
(Dalkon shield).

(Dalkon shield).

surface corrosion,

increased

on Cu wire (Cu-7).

tail

to

provides niche

of Dalkon shield tail.

citations
IUDand bacterial colonization of the string.
Tatum et al. also demonstrated that the
structural design of the Dalkon shield IUDtail
permitted a "wicking effect" whereby bacteria
continually gained access to the endometrial
cavity {67). The Dalkon shield IUDtail has a
polyfilamentous nylon core surrounded by a nylon
sheath. During manufacture the nylon sheath was
damaged at points where knots were tied and at
these sites biologic degradation of the nylon
was greatest.
The knots 1~ere tied at the distal
end of the tail and al so at the point where the

previously {16,56,64).
The Dalkon shield IUD is a classic example
of biotransformation
resulting in IUD-related
disease.
Gaudoin et al. used SEMto show that
the Dalkon shield was altered in situ and that
both surface depositions and alterations
were
produced (14). Roberts et al. {57) revealed,
with SEM, that the Dalkon shield IUDtail
have demonstrated bacteria on and in the
Dalkon shield tail.
Tatum et al. {66,67), using
incident LM, TEMand bacteriologic studies,
demonstrated disintegration
of the Dalkon shield
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tail attached to the IUD, the latter knot being
within the cavum uteri when the IUDwas in
place. Using correlated in vivo and in vitro
studies, Tatum et al. ( 67) demonst rated that
motile bacteria, pathogens included, could gain
access to the inner core of the string.
The
organisms enter either through the open end in
the vagina or via mechanically induced or hydrolyzed breaks in the distal knot, travel up the
string and gain access via the proximal knot
site where the string is attached to the tail.
In the case of the Dalkon shield a combination
of poor architectural
design and inadvertent
poor choice in materials conspired to place the
users of these IUDs at high risk for inflammatory and infectious disease.
The material deposited upon the surface of
the IUD, the biodeposit, is not composed solely
of inorganic Ca salts.
Using SEM, TEMand
XRMA,Sheppard and Bonnar studied deposits on
the surface of a variety of IUDs (Lippes loop,
Saf-T-Coil, Dalkon shield, Cu-7 and
Progestasert™) and found Ca bearing materials
which tended to increase in amount with the time
the IUDwas in situ ( 63). They al so found cells
and fibrin deposits as integral parts of the
biodeposit material.
In the most recent study,
Khan and Wilkinson, using SEM, TEM,XRMA
and xray diffraction,
studied the surface deposits on
a variety of IUDs {36,37). Their data indicated
that most of the Ca salts present were carbonates in the form of ca 1cite.
These Ca salts
seemed to be intimately intermixed and associated with cellular and non-cellular materials
to produce a complex crust.
Their studies
revealed the structural organization of the
biodeposit:
the layer closest to the IUDwas
fibrillar
and rather amorphous and the outer
crust contained crystalline materials.
These
results suggested a definite sequence in crust
formation, findings entirely consonant with the
frequent observation that the formation of IUD
biodeposit is time dependent.
IUD Related Disease
These well documented changes which involve
the IUD, the host and the host-IUD interface may
be operative in the genesis of IUD-related
disease and demand interpretation
in that context.
To do so it is important to place
IUD-related disease in perspective.
The studies
cited above demonstrate that changes of the IUD
and of the host tissues are both time related,
as is the generation of IUD-related disease.
Prolonged duration of the IUD in utero is not,
however, synonomous with IUD-related disease.
Kaye et al. have shown in their patient population that long term use of IUDs is not associated with increased morbidity or mortality
{33). They studied 200 womenwho used a variety
of IUDs {Lippes loops-A, -C and -D; Dalkon
shield; Saf-T-Coil; Cu-T200). In this population there were 670 insertions of IUDs and
they experienced as complications up to 8%
pregnancies and 3.2% infections, none of the
latter being serious.
These womenhad worn
IUDs continuously for at least 10 years; during
this time period there had been numerous
reinsertions of 'fresh' IUDs.

Nonetheless, IUDuse is associated with
disease.
Kahn and Tyler, in a six month study
of 7900 IUD-related hospitalizations
during
1973, derived an estimated morbidity rate of
3-10 hospitalizations/1,000
woman-years of IUD
use and an estimated death rate of 1.0-7.3
deaths/1,000,000 women-years of IUDuse (31,32).
Thus, there seems to be a category of patients,
perhaps different from the private practice,
well motivated, middle class womenin the study
of Kaye et al. {33), who are at risk for serious
disease and even death as a result of IUDuse.
The relationship between socioeconomic status,
sexual practices and IUD-related disease are
thoroughly discussed elsewhere {35,66).
Some insight may be obtained by examining
the type of IUD-related disease and relationship
of those diseases to the type of IUDused as
shown in Tables 7 and 8 respectively.
From
Table 7 it is apparent that minor IUD-related
disease is rare to uncommonand is associated
with physiologic alterations.
These physiologic
alterations usually occur so soon after IUD
insertion that the processes of biotransformation do not seem likely causes of the minor
IUD-related diseases.
The major IUD-related
diseases, on the other hand, are temporally concordant with the appearance of host tissue
changes and IUDbiotransformation processes.
Amongst the variety of mechanisms known or
thought to be at the root of serious IUD-related
disease, inflammation and infection are those
which occur most commonly. Similarly, when
IUD-related disease is classified according to
type of IUDused {Table 8), it is apparent that
infectious/inflammatory
disease is the most common type of disease process and is also most
commonlyassociated with the more serious
complications of IUD-related disease, reproductive failure and death.
We propose that serious IUD related disease
is caused by or is a direct consequence of
biotransformation processes and that most of the
induced diseases are mediated by inflammation
and infection operating either separately or in
tandem {61). We propose that inflammation/
infection is the paradigm of serious IUD-related
disease, the interaction of these processes
being demonstrated in Fig. 18. As proof of the
central role of biotransformation processes in
the initiation of IUD-related disease we invoke
the multitude of morphologic and microanalytic
studies cited above; among these reports the
results by Khan et al. are typical.
The observation by Khan and Wilkinson {36)
that there is an amorphous layer immediately
adjacent to the IUD upon which the proteacalcareous deposit forms is important and
suggests that the first step in IUDbiodeposition is the formation of a proteinaceous surface
coating similar to the salivary pellicle which
precedes dental plaque formation (48). Because
IUDs, except for those which are medicated, do
not interfere with the menstrual process the IUD
is exposed during menses to a wide variety of
proteins ordinarily confined to the stroma by
the endometrial epithelium.
These proteins may
add to the surface coating of the IUD. Amongst
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Fig. 18:

Cartoon characterization
of the proposed paradigm for serious IUD-related disease.
The
presence of the IUD induces changes in the host tissues and a host reaction which alters
the IUD. These alterations
of the IUD result in accentuation of the host responses. Changes
in the host tissues acting in concert with the altered host/IUD milieu result in the
inflammatory and infectious diseases which constitute the majority of serious IUD-related
disease.

these stromal proteins are the ubiquitous extracellular matrix proteins, laminin, fibronectin
and collagen IV.
It is important to note that fibronectin
binds non-covalently to gram-positive and gramnegative bacteria and yeasts and that laminin
receptors have been identified on invasive
strains of S. aureus {44, 70). Vercellotti et
al. have shownthaf some gram-positive bacteria
bind to and may be aggregated by fibronectin,
laminin and collagen IV; in this study the
authors concluded that, "These adhesion molecules play a role in the normal colonization of
sites by microorganisms and in invasion during
pathogenesis" (71). Others have shown that all
the epithelia of the reproductive tract, including the endometrium, have a prominent glycocalyx.
In the vagina it is thought that, "The

adherence of many types of bacteria to the vaginal epithelial
eel ls appears to be effected by
the interaction of polyanionic components on the
surface of both the bacterial and epithelial
cells" {38). Such adhesion mechanisms apparently play a role in Fallopian tube infections (9)
and may be similarly operative in the colonization of biotransformed IUDs by pathogens.
Further supporting evidence for these adhesion mechanisms may be found in SEMstudies of
osteomyelitis in which infecting bacteria grow
on the dead bone, essentially
a foreign body, in
coherent microcolonies found within an adherent
biofilm (19). The biofilm of osteomyelitis has
a fibrous matrix and contains host cells and
bacteria surrounded by matrix. The bacteria are
further enveloped by an exopolysaccharide
polymer, which stains with ruthenium red. The
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TABLE7
CLASSIFICATION
OF IUD-RELATED
DISEASESANDCOMPLICATIONS
Classification
I. Minor

II. Major

Frequency

Time Frame

Mechanism(sl

1. Syncope

Unusual-rare

Vagal bradycardia,

2.Perforation

_$_8.
7/1, 0()0

3.Expulsion
4.Cramping &
bleeding
5.Fe-deficiency
anemia
6.Pregnancy

0. 7-19. 3/1,000
4.0-14.7/1,000

Immediate
insertion
Insertion and
later
First month
Early and late
Later

Menorrhagia

Rare

Not specific

Not defined

I.Chronic
salpingitis
2.Infertility

Up to 47%

3. Ectopic pregnancy

11

4.Septic
5.PID

?
1.3-8%

Not defined
Increases
after 2 years
Not specified
Not defined; inflammation/infection
Not specific
Unknown;salpingitis?
Design failure
?
Not defined
Increases
after 2 years
Septic abortion
Second
trimester
Puerperal perforation and migration
Anticoagulant associated hemorrhage
Usually infection
1 month 2 yea rs

~

abortion

?

Increased
5%"

6. Fetal loss

10-5 □ xa

7.GI perforation
8.Medication
9.Death

Rare
Rare
1. 0-7. 3/
1,000,000
womenyears

Faulty insertion,

hypotension
design failure,

Poor size match
Size, shape and position

etc.

of IUD

?

no precise data available.
no data available.
a= increase over spontaneous incidence in absence of IUD.

authors of the osteomyelitis studies conclude
that, "The adherent mode of growth may reduce
the susceptibility
of these organisms to host
clearance mechanisms and antibiotic therapy and
thus may be a fundamental factor in acute and
chronic osteomyelitis".
Such mechanisms of
escape from host defenses may permit growth of
pathogens within IUD biodeposits and the attainment of sufficient numbers to establish an
infectious disease process.
The model which we propose for IUD-related
diseases is shown in Figure 19. The model is
concordant with our present understanding of the
types of disease processes associated with IUDs,
the types of IUDs associated with disease and
with the multitude of structural and microanalytic studies of IUDs. The construction of the
model has been entirely dependent upon data from
morphologic and microanalytic studies.
Our
understanding of IUD-induced alterations
in host
tissues, the alterations on and of the IUD and
the apparent interactions between these forces
to produce IUD-related disease, in fact, have
come as a result of morphologic analysis,
thorough microanalytic probing and careful
correlation of clinical and pathological observations.

TABLE9
RECOMMENDATIONS
REGARDING
PATIENTCARE
1.

Change IUDs regularly, perhaps every two
years, and interrupt the biotransformation
process.

2.

Carefully counsel patients about complications, not only what can happen but also
which alterations
in normal patterns are
warning signs.

3.

tvaluate and observe with great care those
womenwho are symptomatic no matter how
protean their symptoms. Consider removing
the IUD and using an alternative means of
contraception.

4.

Examine carefully the removed IUD and
adherent material, no matter how small the
fragments may be.

5.

Follow carefully

those womenusing IUDs.
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TABLE8
CLASSIFICATION
OF IUD-RELATED
DISEASEBY IUD TYPE
PROGNOSIS
REPRODUCT!
VE
INCAPACITY FAILURE

LIMITED

TYPE

DISEASE

PATHOGENESIS

1. Diamond +Au

Infections

Non-inert devices

DEATH

+

+

+

2. Silkworm gut

+

+

+

3. Silkworm gut and Ag

+

+

+

+?

Device failure

Fragmentation
by body systems

+

Infection,
perforation,
menorrhagia

Chemical irritation

+

+

Saf-T-Coil

Minor diseases

Not apparent

+

+

Bi rnl1eg bow

Major diseases

? Inflammation/

+

+

Lippes loop

Minor diseases,
Major diseases,

+

+

4. Nylon
5. Stainless

steel

6. Plastics:

Dalkon shield

Not apparent
Inflammation/
infection

Infert i 1ity

+

p ID

+

Mid-trimester
Abortion

Design failure
Inflammation/
infection
+

PIO

Cu devices

Minor diseases,
Major diseases,
Infert i 1i ty
PIO

Medicated

+?

infection

Not apparent

+

Inflammation/
infection

+
+

Minor diseases,
Hormonally related
Major diseases,
Ectopic pregnancy Unknown

+

+

+

+

+

+
+

+

+

+

+

+

lQ_jJague

IUDs returned to use at a time permissive
to the introduction of new devices, permissive
to a fault, in fact.
It is difficult
to conceive how such devices could be introduced today
without studies more thorough than were performed in the 1960s, recognizing that at that
time bioengineering and materials science were
fledgling areas.
Today the truly inert IUD
remains as elusive as ever and although
IUD-related disease persists the IUDcontinues
to be used by mi71ions of women. Even though
two maJor manufacturers of IUDs have withdrawn
from the market there remain others and the IUD,
as noted above, remains a popular contraceptive
device. Those IUDs still in use are not exempt
from the types of changes or proposed mechanisms
of disease listed above. It is important,
therefore,
that patient care and observation be
modulated by our current understanding.
Table 9

lists recommendations regarding care of patients
with IUDs.
It also seems unwise to ignore the efficacy
and popularity of IUDs as a contraceptive device.
Rather, we should capitalize upon our experience
to date, continue to carefully observe those IUDs
which remain in use and design IUDs which are
both safer and effective.
When possible future
trends in IUD design and evaluation are considered (Table 10) it is apparent that morphologic and microanalytic studies must be continued
by multidisciplinary
teams.
Acknowledgements
The authors thank Ann Rose for her able
preparation of the manuscript and Philip Mitchell
and Dana Gaddy-Kurten for their photographic
expertise.

751

W.A. Schmidt, K.L. Schmidt

recent event
layer
/
I\ I\ I\ I\ I\ I\ I\ I\ I\ I\ I\ I\ htJTOral
druble layers:l
proteo-calcareus _____________________ cell
dE.'f.X)sition'--... 0 0 0 0 0 0 0 0 0

~<>-----

biodeposition

_j

BIOTR/¥'-ISFORMATION

h1JTDral

cell

biocegradation

CALCIIJ,1
SALTS

PROlIINS
uterine "fluid"
uterine secretions
blood canponents
eel lular canponents
interstitial c011ponents
productsof inflamration--~-1
bacterial canponents

IUDdesign
&

rbst origin

~-?--

canponent
s

VARIABLES
?

Biocegradation
water/non--enzyretic
hydrolysis(polyester bards)
enzyretic proteolysis (nylonilTlides)
Tirre
Fig. 19:

netails of the biotransformation processes which contribute to the genesis and progress of
serious IUD-related disease.
a. a cartoon view of the IUD surface, seen on cross section.
The protea-calcareous
deposition is formed from both cellular and humoral components. Under
this layer there are changes which affect the physical structure of the IUD; these changes may
involve dissolution of or changes in the mechanical properties of the IUDand its string.
The outer layer of the biodeposit represents the "recent event layer" within which may be
found RBCs, WBCs,protein strands, crystalline
material and bacteria of various kinds.
b. the variables which contribute to the two major components of the biodeposit are shown.
The major variables seem to be proteins of various kinds, the nature of the materials of which
the IUD is made, Ca salts, biodegradation processes and time in situ.
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CV
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LM
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OCPs

Acid phosphatase
Alkaline phosphatase
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Pelvic inflammatory disease
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Platinum
Red blood eel ls
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Scanning electron microscopy
Transmission electron microscopy
United States
White blood cells
x-ray microanalysis
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TABLE10

6. Casslen B, Ohlsson K. (1981). Cyclic
variation of proteinase inhibitors in human
uterine fluid and influence of an IUD.
Contracep. 1l_:425-434.

FUTURE
TRENDSIN IUD DESIGNANDEVALUATION
1.

Continue to explore the application of new
materials, such as polyether urethane.

2.

Continue to explore the role of metals in
terms of their capacity to promote contraception, inflammation and bacteriostasis.

3.

Continue to explore the nature of biotransformation, its consequences, the molecules
which participate
in the phenomenon and the
control mechanisms involved.

5.

Design and fund these studies to allow longterm follow-up of no less than 5 years,
utilizing multidisciplinary
teams of
materials scientists,
reproductive biologists, obstetrician/gynecologists
and reproductive pathologists.

7.

8. Collins JA, Gillett PG, Perlin IA, Embil JA,
Zayid I, Richards G, Kirk ME. (1984).
Microbiological and histological
findings in the
fallopian tubes of womenusing various contraceptive methods. Contracep. lQ_:457-466.

Continue to explore the role of the IUDas a
means of delivering pharmacologic agents
which may influence contraception, the host
response, biotransformation and control of
micro-organisms.

4.

6.

7. Casslen B, Thorell J, Astedt B. (1981).
Effect of IUD on urokinase-like immunoreactivity
and plasminogen activators in human uterine
fluid.
Contracep. 23:435-439.

9. Cooper MO,Jeffery C. (1985). Scanning and
transmission electron microscopy of bacterial
attachment to mucosal surfaces with particular
reference to the human fallopian tube. Scanning
Electron Microsc. 1985; II:1183-1190.
10. Cuadros A, Hirsch JG. (1972). Copper on
intrauterine
devices stimulates leukocyte exudation. Science 175:175-176.
11. F.l-Maraghy MA, Abou Senna IY, El-Thewey F.
(1982). l:ndometrial picture with oestrogenloaded intrauterine
device. Contracep.
25: 605-611.

Include in such studies a wide range of
patients of diverse races, socioeconomic
levels, sexual behaviors and marital and
reproductive status.
Use the full
basic science
so useful in
knowledge of

12. Faundes A, Segal SJ, Adejuwon CA, Brache V,
Leon 0, Alvarez-Sanchez F. (1980). The
menstrual cycle in womenusing an intrauterine
device. Fertil.
Steril.
34:427-430.

range of clinical studies and
examinations which have proven
providing our current fund of
IUD-related disease.

13. Fornari ML. (1974). Cellular changes in
the glandular epithelium of patients using IUD
- a source of cytologic error.
Acta Cytol.
18:341-343.
14. Gaudoin R, Brault R, DomuradoD. (1976).
Contraceptifs intra-uterins
-etudes sur le
dalkon shield par microscopie electronique a
balayage. Union Med. Can. ~:90-98.
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MINORIUD-RELATED
DISEASE
conditions which do not threaten or destroy reproductive
capacity
seriously impair or permanently
destroy work capacity
require more than ambulatory care
most are physiologic reactions or
limited excesses or normal physiologic
functions (ie, cramping and expulsion
of the IUD)
are usually treated easily, inexpensively and do not need extensive follow-up

Discussion with Reviewers
S. R. Khan: Knowing what we know now, would you
recommend use of the IUD as a contraceptive
device?
Authors: This is a difficult
question; its
answer must be addressed at two levels.
The
literature
which we have reviewed and multiple
other articles which we have not cited attest to
the usefulness of the IUD as a means of contraception.
In addition, this collective
experience clearly identifies the conditions
under which IUD use is likely to be safe and
those conditions in which serious disease may be
encountered as a direct result of using an IUD.
Unfortunately, there is no guarantee that significant IUD-related morbidity will not be encountered under the best circumstances.
The
inability to predict which womenare at risk for
serious IUD-related disease leads to threatening
medico-legal liability.
In the US, the
IUD-related litigation
risk is well understood
by medical and legal professionals and the women
who use IUDs. Georgia Dullea's article in the
New York Times (Liability Crisis Complicates
Contrace pt ion; Style, B8, Monday, May 19, 1986)
is perhaps a fitting puhlic summary; she quotes
therein the comments of one gynecologists:
"No
sane physician would dare give an IUDtoday,
except to his wife".

MAJORIUD-RELATED
DISEASES
conditions which are life threatening or fatal
threaten, impair significantly
or
destroy reproductive capacity
seriously impair or permanently destroy
work capacity
require in-patient care and extensive
follow-up
often require surgical intervention
Reviewer V: Whydon't you get oral abscesses
and infections with prolonged dental fillings?
Should IUDs be made of similar materials?
Authors: There is an instance in which intraoral-dental
'crust' formation is associated with
a disease process similar to serious infections
related to IUD use. The formation of dental
plaque, particularly
where that plaque extends
into the gi ngi vo-dental sul cus, is related to
periodontal disease and tissue destruction.
In both settings it appears that the crust and
micro-organisms play a synergistic role. There
is much merit to the suggestion that exploration
of a wider range of materials might produce a
safer IUD.

Reviewer V: Whywere the IUDs collected in 1985
sent to you?
Authors: It is t~e practice in our institution
tosena all IUDs which are removed to the pathology laboratory for examination. This allows
the attending physician to explore the possibility of clinically silent but serious
IUD-related disease when the results of the
pathologist's
examination suggests such a possibility.
Examples of suggestive findings include: Gupta bodies on CVsmears obtained
coincident with IIJD removal, purulent and malodorous deposits on the IUD and string, and
significant histopathological
alterations
in
tissues attached to the IUD and string.
Reviewer V: What is a major IUD-related disease
and what is a minor one?
Authors: In the course of our extensive l iterature -revie1~ we perceived the need to distinguish
amongst the wide variety of IUD-related complications.
As noted by Reviewer V, "IUD associated complications occur most frequently
during the first 12 weeks of insertion---."
These complications are, for the most part,
minor occurrences and transient situations which
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